FDA ap­proves new in­di­ca­tion for Arde­lyx's tena­panor for serum phos­pho­rus con­trol

Near­ly a year af­ter suc­cess­ful­ly ap­peal­ing a com­plete re­sponse let­ter, Arde­lyx won FDA ap­proval on Tues­day for Xphozah (tena­panor) for the con­trol of serum phos­pho­rus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER